Tivorsan Pharmaceuticals Inc.

Recent volatility in the stock market may be making investors nervous on Wall Street, but experts and biotech insiders at the BIO CEO & investor conference in New York agreed the outlook for investing

It's been a busy week for Janssen Pharmaceuticals Inc. , which picked up a breakthrough therapy status for one of its candidates and requested a priority review for an sBLA. Two companies picked up

New At The Helm Company Changes ABUSHAKRA , Susan, MD To: Alzheon Inc. , CMO (September) From: Transition Therapeutics Inc., CMO Phone: 857-214-7242 ALATARIS , Kostantinos, PhD To: Zosano P